Martin, Reuben L;
Heifetz, Alexander;
Bodkin, Mike J;
Townsend-Nicholson, Andrea;
(2024)
High-Throughput Structure-Based Drug Design (HT-SBDD) Using Drug Docking, Fragment Molecular Orbital Calculations, and Molecular Dynamic Techniques.
Methods in Molecular Biology
, 2716
pp. 293-306.
10.1007/978-1-0716-3449-3_13.
Preview |
Text
Townsend-Nicholson_High-Throughput Structure-Based Drug Design Using Drug Docking, Fragment Molecular Orbital Calculations, and Molecular Dynamic Techniques_AAM.pdf Download (273kB) | Preview |
Abstract
Structure-based drug design (SBDD) is rapidly evolving to be a fundamental tool for faster and more cost-effective methods of lead drug discovery. SBDD aims to offer a computational replacement to traditional high-throughput screening (HTS) methods of drug discovery. This "virtual screening" technique utilizes the structural data of a target protein in conjunction with large databases of potential drug candidates and then applies a range of different computational techniques to determine which potential candidates are likely to bind with high affinity and efficacy. It is proposed that high-throughput SBDD (HT-SBDD) will significantly enrich the success rate of HTS methods, which currently fluctuates around ~1%. In this chapter, we focus on the theory and utility of high-throughput drug docking, fragment molecular orbital calculations, and molecular dynamics techniques. We also offer a comparative review of the benefits and limitations of traditional methods against more recent SBDD advances. As HT-SBDD is computationally intensive, we will also cover the important role high-performance computing (HPC) clusters play in the future of computational drug discovery.
Type: | Article |
---|---|
Title: | High-Throughput Structure-Based Drug Design (HT-SBDD) Using Drug Docking, Fragment Molecular Orbital Calculations, and Molecular Dynamic Techniques |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1007/978-1-0716-3449-3_13 |
Publisher version: | https://doi.org/10.1007/978-1-0716-3449-3_13 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
Keywords: | Structure-based drug design, drug development, drug docking, fragment molecular orbitals, molecular dynamics, high-performance compu-ng, virtual screening |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Structural and Molecular Biology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10179105 |
Archive Staff Only
View Item |